Protagonist Therapeutics, Inc. (PTGX)
84.60
+3.24
(+3.98%)
USD |
NASDAQ |
Jan 14, 14:34
Protagonist Therapeutics Price: 84.60 for Jan. 14, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Johnson & Johnson | 218.13 |
| ADMA Biologics, Inc. | 18.01 |
| Bristol Myers Squibb Co. | 56.90 |
| MannKind Corp. | 5.59 |
| Regeneron Pharmaceuticals, Inc. | 754.83 |
Price Related Metrics
| PE Ratio | 133.59 |
| PS Ratio | 25.95 |
| Price to Book Value | 8.194 |
| Price to Free Cash Flow | 85.20 |
| Earnings Yield | 0.75% |
| Market Cap | 5.289B |
| Operating PE Ratio | 285.58 |
| Normalized PE Ratio | 133.59 |